Respiratory Inhaler Device Market Share

Regionally, the global respiratory inhaler device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America industry is predicted to dominate majority revenue share by 2037, on the back of presence of a highly established healthcare infrastructure. Furthermore, the Centers for Disease Control and Prevention states that chronic obstructive pulmonary diseases affect more than 15 million Americans. Owing to this, the global market is projected to witness remarkable growth during the forecast period. Apart from this, a report published by the National Center for Biotechnology Information states that 5% of adults suffer from acute bronchitis every year. A person suffering from bronchitis might receive a nebulizer breathing treatment which calms the inflation in the mucous membrane and allow the body to start to heal.

The Asia Pacific region is also estimated to witness significant growth during the forecast period on the back large number of people suffering from respiratory diseases.  Also, the data released by the WHO, countries such as, Bangladesh, India, and Pakistan are among the most polluted countries in the world, all exceeding WHO guidelines by 10 times. The increasing air pollution in the region is leading to severe respiratory diseases among the population, which is the reason the global respiratory inhaler device market is projected to witness significant growth during the forecast period.